| Sep 12, 2025 |
Sep 16, 2025 |
Karyopharm Therapeutics Inc.
|
SVP, General Counsel&Secretary |
Sell |
77.5
|
+378
|
1.80%
|
✗
|
$1.5K |
| Mar 4, 2025 |
Mar 6, 2025 |
Karyopharm Therapeutics Inc.
|
SVP, General Counsel&Secretary |
Sell |
46.3
|
-2,793
|
-11.72%
|
✗
|
$17.6K |
| Sep 4, 2024 |
Sep 5, 2024 |
Karyopharm Therapeutics Inc.
|
SVP, General Counsel&Secretary |
Sell |
47.5
|
-3,971
|
-1.43%
|
✗
|
$2.9K |
| Feb 29, 2024 |
Mar 4, 2024 |
Karyopharm Therapeutics Inc.
|
SVP, General Counsel&Secretary |
Sell |
46.3
|
-20,549
|
-6.89%
|
✗
|
$24.1K |
| Sep 1, 2023 |
Sep 5, 2023 |
Karyopharm Therapeutics Inc.
|
SVP, General Counsel&Secretary |
Sell |
47.5
|
-3,888
|
-2.66%
|
✗
|
$5.2K |
| Feb 28, 2023 |
Mar 2, 2023 |
Karyopharm Therapeutics Inc.
|
SVP, General Counsel&Secretary |
Sell |
91.3
|
+63,122
|
76.05%
|
✗
|
$20.8K |